These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15724943)

  • 41. [Alleviating pain and preventing inflammation with selective COX-2 inhibitors. Prescribing with confidence in the future].
    MMW Fortschr Med; 2005 Mar; 147(9):12. PubMed ID: 15794346
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.
    Sidiropoulos PI; Hatemi G; Song IH; Avouac J; Collantes E; Hamuryudan V; Herold M; Kvien TK; Mielants H; Mendoza JM; Olivieri I; Østergaard M; Schachna L; Sieper J; Boumpas DT; Dougados M
    Rheumatology (Oxford); 2008 Mar; 47(3):355-61. PubMed ID: 18276738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 44. Identifying suboptimal management of persistent pain from integrated claims data: a feasibility study.
    Goldberg GA; Kim SS; Seifeldin R; Haberman M; Robinson D
    Manag Care; 2003 Aug; 12(8 Suppl Improving pain):8-13. PubMed ID: 13677058
    [No Abstract]   [Full Text] [Related]  

  • 45. The payer side: patient outcomes and cost.
    Fish L; Nicholson BD
    Am J Ther; 2008; 15 Suppl 10():S20-2; discussion S22-3. PubMed ID: 19127125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
    Hilmi I; Goh KL
    Chin J Dig Dis; 2006; 7(1):1-6. PubMed ID: 16412030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic idiopathic pain syndromes.
    Sen D; Christie D
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):369-86. PubMed ID: 16546062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist.
    McDermott ME; Smith BH; Elliott AM; Bond CM; Hannaford PC; Chambers WA
    Fam Pract; 2006 Feb; 23(1):46-52. PubMed ID: 16107494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Dexketoprofen-Trometamol--a new analgesic for the treatment of severe acute pain].
    Z Orthop Ihre Grenzgeb; 1999; 137(3 Suppl):1-4. PubMed ID: 10434387
    [No Abstract]   [Full Text] [Related]  

  • 51. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 53. Basic principles in the management of pain.
    DeFelice EA; Sunshine A
    Triangle; 1981; 20(1-2):43-8. PubMed ID: 6973869
    [No Abstract]   [Full Text] [Related]  

  • 54. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor.
    O'Connor MB; Murphy E; Phelan MJ; Regan MJ
    Eur J Neurol; 2008 Jan; 15(1):e1. PubMed ID: 18171381
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors.
    Huntjens DR; Danhof M; Della Pasqua OE
    Rheumatology (Oxford); 2005 Jul; 44(7):846-59. PubMed ID: 15855183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 58. Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis.
    Vera-Portocarrero LP; Xie JY; Kowal J; Ossipov MH; King T; Porreca F
    Gastroenterology; 2006 Jun; 130(7):2155-64. PubMed ID: 16762636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?
    Heeneman S; Donners MM; Bai L; Daemen MJ
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):345-64. PubMed ID: 17338677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic pain management: therapy, drugs and needles.
    Ho KY; Siau C
    Ann Acad Med Singap; 2009 Nov; 38(11):929-30. PubMed ID: 19956812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.